Tirzepatide currently being a twin GLP-1 and GIP agonist, it is actually proposed which the GIP part of dual agonism might be to blame for the additional benefit, provided the prospective benefit of GIP receptor agonism on peripheral insulin sensitization. As a result, tirzepatide was more effective than dulaglutide in https://franciscoslbpd.shoutmyblog.com/27745915/research-chemicals-sites-for-dummies